Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 73

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 73
---
 on May 8, 2023 (the “Sabby Note”).         |

| ● | On                                                                                                                                   
 July 14, 2023, we issued a total of 488 restricted shares of our common stock to BioIntelect Pty Ltd as deferred equity compensation 
 valued in the amount of $155,000.                                                                                                    |

| ● | On                                                                                                                                      
 July 14, 2023, we converted the entirety of debt owed to a noteholder to 3,583 shares of our common stock at the conversion price equal 
 to the initial public offering price, of which were issued to Xu Yu.                                                                    |

| ● | On                                                                                                                        
 July 14, 2023, we issued 18,473 shares of common stock to Knight Therapeutics (Barbados) Inc.) (“Knight”) upon conversion 
 of debt owed to Knight.                                                                                                   |

| ● | On                                                                                                                                        
 July 28, 2023, we issued 760 restricted shares of our common stock to Knight upon conversion of 2,162 shares of Series A Preferred Stock, 
 at the conversion rate price detailed in Note 6 to the accompanying consolidated condensed financial statements.                          |

<div align='center'>II-2</div>

The issuances of shares of common stock listed
above were deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder in that
the issuance of securities did not involve a public offering.

| ● | On                                                                                                                                     
 the effective date of our initial public offering registration statement, we issued 1,158 shares of our common stock to Mountjoy Trust 
 as a result of the conversion of the Convertible Promissory Note we issued to Mountjoy Trust on May 19, 2022 (the “Mountjoy Note”).    |

| ● | From                                                                                                                                   
 October 2024 to January 2025, we issued an aggregate of 579,711 shares of common stock upon the exercise of pre-funded warrants issued 
 to investors in the September 2025 private placement.                                                                                  |

The issuance of the capital stock listed above
was deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder in that the issuance
of securities were made to an accredited investor and did not involve a public offering. The recipient of such securities represented
its intention to acquire the securities for investment purposes only and not with a view to or for sale in connection with any distribution
thereof